The Gut-Brain Axis: How Your Digestive System Communicates with Your Brain
Last reviewed: 07:02 Ngày 21 tháng 3 năm 2026
The gut-brain axis is a bidirectional communication network linking the central nervous system with the enteric nervous system — an intricate mesh of over 500 million neurons embedded in the wall of the gastrointestinal tract. This communication occurs through multiple pathways including the vagus nerve, the immune system, the endocrine system, and microbial metabolites. The vagus nerve, the longest cranial nerve in the body, serves as a direct physical connection between the gut and the brainstem, transmitting sensory information about the state of the digestive tract to the brain and relaying motor signals in return. Research using vagotomy models in animals has demonstrated that severing this nerve can abolish certain gut-mediated effects on brain function, highlighting its central role in gut-brain communication.
The gut microbiome plays a significant role in gut-brain signaling through the production of various neuroactive metabolites. Certain gut bacteria produce or influence the production of neurotransmitters including serotonin, gamma-aminobutyric acid (GABA), dopamine, and norepinephrine. Approximately 90 to 95 percent of the body's serotonin is produced in the gut, primarily by enterochromaffin cells in the intestinal lining, and gut bacteria may influence this production through their metabolic activities. Short-chain fatty acids such as butyrate, produced by bacterial fermentation of dietary fiber, may also play signaling roles in the gut-brain axis by crossing the blood-brain barrier and influencing neuroinflammatory processes. This emerging understanding has led some researchers to coin the term 'psychobiotics' to describe probiotics that may influence brain function.
Clinical research on the gut-brain axis in humans is still in its relatively early stages, but several findings are noteworthy. Studies have observed that individuals with IBS and functional dyspepsia frequently report co-occurring mood disturbances, and conversely, psychological stress is a well-documented trigger for gastrointestinal symptoms. Some clinical trials have investigated whether specific probiotic strains may influence stress responses and mood. For instance, Bifidobacterium longum 1714 was studied in a randomized controlled trial in healthy volunteers and was associated with reduced cortisol output and subjective stress measures. Lactobacillus rhamnosus GG has been studied for its potential effects on gut-brain communication, though results have been mixed and larger trials are needed. Omega-3 fatty acids have also been researched for their potential anti-inflammatory effects that may support both gut and brain health.
It is crucial to maintain scientific rigor when discussing the gut-brain axis, as the popular media often overstates the current state of evidence. While animal studies have demonstrated dramatic effects of microbiome manipulation on behavior, translating these findings to humans has proven more complex. Most human trials to date have been small in scale and short in duration, and the effects observed have generally been modest. The gut microbiome is also highly individual, meaning that interventions effective in one person may not produce the same results in another. Nevertheless, the gut-brain axis represents one of the most exciting frontiers in biomedical research, and ongoing large-scale studies may provide clearer guidance on how to leverage this connection for health benefits in the coming years.
The gut microbiome plays a significant role in gut-brain signaling through the production of various neuroactive metabolites. Certain gut bacteria produce or influence the production of neurotransmitters including serotonin, gamma-aminobutyric acid (GABA), dopamine, and norepinephrine. Approximately 90 to 95 percent of the body's serotonin is produced in the gut, primarily by enterochromaffin cells in the intestinal lining, and gut bacteria may influence this production through their metabolic activities. Short-chain fatty acids such as butyrate, produced by bacterial fermentation of dietary fiber, may also play signaling roles in the gut-brain axis by crossing the blood-brain barrier and influencing neuroinflammatory processes. This emerging understanding has led some researchers to coin the term 'psychobiotics' to describe probiotics that may influence brain function.
Clinical research on the gut-brain axis in humans is still in its relatively early stages, but several findings are noteworthy. Studies have observed that individuals with IBS and functional dyspepsia frequently report co-occurring mood disturbances, and conversely, psychological stress is a well-documented trigger for gastrointestinal symptoms. Some clinical trials have investigated whether specific probiotic strains may influence stress responses and mood. For instance, Bifidobacterium longum 1714 was studied in a randomized controlled trial in healthy volunteers and was associated with reduced cortisol output and subjective stress measures. Lactobacillus rhamnosus GG has been studied for its potential effects on gut-brain communication, though results have been mixed and larger trials are needed. Omega-3 fatty acids have also been researched for their potential anti-inflammatory effects that may support both gut and brain health.
It is crucial to maintain scientific rigor when discussing the gut-brain axis, as the popular media often overstates the current state of evidence. While animal studies have demonstrated dramatic effects of microbiome manipulation on behavior, translating these findings to humans has proven more complex. Most human trials to date have been small in scale and short in duration, and the effects observed have generally been modest. The gut microbiome is also highly individual, meaning that interventions effective in one person may not produce the same results in another. Nevertheless, the gut-brain axis represents one of the most exciting frontiers in biomedical research, and ongoing large-scale studies may provide clearer guidance on how to leverage this connection for health benefits in the coming years.